Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.

Wright IA.

Gastroenterol Nurs. 2000 Nov-Dec;23(6):275-80. Review.

PMID:
11854972
3.

Managing depression during hepatitis C treatment.

Sockalingam S, Abbey SE.

Can J Psychiatry. 2009 Sep;54(9):614-25. Review.

PMID:
19751550
4.

A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients.

Weinrieb RM, Auriacombe M, Lynch KG, Chang KM, Lewis JD.

J Clin Psychiatry. 2003 Dec;64(12):1502-10. Review.

PMID:
14728113
5.

Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis.

Ehret M, Sobieraj DM.

Int J Clin Pract. 2014 Feb;68(2):255-61. doi: 10.1111/ijcp.12268. Epub 2013 Dec 22. Review.

PMID:
24372654
6.

Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.

Galvão-de Almeida A, Guindalini C, Batista-Neves S, de Oliveira IR, Miranda-Scippa A, Quarantini LC.

Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):401-5. doi: 10.1016/j.genhosppsych.2010.03.001. Epub 2010 Apr 2. Review.

PMID:
20633744
7.

Hepatitis C and depression.

Yates WR, Gleason O.

Depress Anxiety. 1998;7(4):188-93. Review.

PMID:
9706456
9.

Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.

Sarkar S, Schaefer M.

Psychosomatics. 2014 May-Jun;55(3):221-34. doi: 10.1016/j.psym.2013.06.015. Epub 2013 Sep 5. Review.

PMID:
24012293
10.

Reactivation of sarcoidosis during interferon therapy.

Li SD, Yong S, Srinivas D, Van Thiel DH.

J Gastroenterol. 2002 Jan;37(1):50-4. Review.

PMID:
11824801
11.

Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature.

Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B.

Dig Dis Sci. 2002 Jul;47(7):1627-31. Review.

PMID:
12141827
12.

Diabetes mellitus during interferon therapy for chronic viral hepatitis.

Mofredj A, Howaizi M, Grasset D, Licht H, Loison S, Devergie B, Demontis R, Cadranel JF.

Dig Dis Sci. 2002 Jul;47(7):1649-54. Review. No abstract available.

PMID:
12141831
13.

[Hepatitis C viral infection and depression].

Lengyel G, Aszalós Z, Tulassay Z.

Orv Hetil. 2007 Jan 7;148(1):11-5. Review. Hungarian.

PMID:
17344112
14.

Hepatitis C, interferon alfa, and depression.

Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM.

Hepatology. 2000 Jun;31(6):1207-11. Review. No abstract available.

PMID:
10827143
15.

The phenomenology and treatment of interferon-induced depression.

Loftis JM, Hauser P.

J Affect Disord. 2004 Oct 15;82(2):175-90. Review.

PMID:
15488246
16.

[A case of ulcerative colitis along with characteristic features on computed tomography (CT), developed by the treatment with interferon for chronic hepatitis C].

Niki T, Nishida K, Honsako Y, Matsumura Y, Ueno H, Fujimi T, Sashikata T.

Nihon Shokakibyo Gakkai Zasshi. 2001 Apr;98(4):399-404. Review. Japanese. No abstract available.

PMID:
11400269
17.

Neurotransmitter changes by interferon-alpha and therapeutic implications.

Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S203-6. Review.

PMID:
14677080
18.

Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV?

Rowan PJ.

World J Virol. 2013 Nov 12;2(4):139-45. doi: 10.5501/wjv.v2.i4.139. Review.

19.
20.

Cytokines and psychopathology: lessons from interferon-alpha.

Capuron L, Miller AH.

Biol Psychiatry. 2004 Dec 1;56(11):819-24. Review.

PMID:
15576057
Items per page

Supplemental Content

Write to the Help Desk